Risk of nonmelanoma skin cancer in patients with psoriatic arthritis and according to bDMARD treatment—a cohort study from the Nordic Arthritis Research Collaboration
ABSTRACT: Objectives: To investigate if psoriatic arthritis (PsA) itself and if biological disease-modifying antirheumatic drugs (bDMARDs) used in PsA are associated with increased risks of nonmelanoma skin cancer (NMSC). Methods: From nationwide health and clinical rheumatology registers in 4 Nord...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2026-06-01
|
| Edice: | EULAR Rheumatology Open |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S3050708126000455 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
